Proanthocyanidins: Impact on Gut Microbiota and Intestinal Action Mechanisms in the Prevention and Treatment of Metabolic Syndrome
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24065369 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Rocío Redondo-Castillejo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacology, Pharmacognosy and Botany Department, Pharmacy School, Complutense University of Madrid, 28040 Madrid, Spain. Hauptthemen laut MEDLINE: Metabolic Syndrome, Proanthocyanidins, Gastrointestinal Microbiome. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 133 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerio de Ciencia e Innovación, España, Spanish Project, Rocío Redondo-Castillejo.
Abstract (Originalsprache)
The metabolic syndrome (MS) is a cluster of risk factors, such as central obesity, hyperglycemia, dyslipidemia, and arterial hypertension, which increase the probability of causing premature mortality. The consumption of high-fat diets (HFD), normally referred to high-saturated fat diets, is a major driver of the rising incidence of MS. In fact, the altered interplay between HFD, microbiome, and the intestinal barrier is being considered as a possible origin of MS. Consumption of proanthocyanidins (PAs) has a beneficial effect against the metabolic disturbances in MS. However, there are no conclusive results in the literature about the efficacy of PAs in improving MS. This review allows a comprehensive validation of the diverse effects of the PAs on the intestinal dysfunction in HFD-induced MS, differentiating between preventive and therapeutic actions. Special emphasis is placed on the impact of PAs on the gut microbiota, providing a system to facilitate comparison between the studies. PAs can modulate the microbiome toward a healthy profile and strength barrier integrity. Nevertheless, to date, published clinical trials to verify preclinical findings are scarce. Finally, the preventive consumption of PAs in MS-associated dysbiosis and intestinal dysfunction induced by HFD seems more successful than the treatment strategy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pharmacology, Pharmacognosy and Botany Department, Pharmacy School, Complutense University of Madrid, 28040 Madrid, Spain.
- Departmental Section of Physiology, Pharmacy School, Complutense University of Madrid, 28040 Madrid, Spain.
- Nutrition and Food Science Department (Nutrition), Pharmacy School, Complutense University of Madrid, 28040 Madrid, Spain.
ORCID-Profile: Rocío Redondo-Castillejo, Aránzazu Bocanegra, Adrián Macho-González, Francisco J Sánchez-Muniz
Förderung
- Ministerio de Ciencia e Innovación, España
- Spanish Project
- Rocío Redondo-Castillejo
Zitieren
APA
Redondo-Castillejo, R., Garcimartín, A., Hernández-Martín, M., López-Oliva, M. E., Bocanegra, A., Macho-González, A., Bastida, S., Benedí, J., & Sánchez-Muniz, F. J. (2023). Proanthocyanidins: Impact on Gut Microbiota and Intestinal Action Mechanisms in the Prevention and Treatment of Metabolic Syndrome. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24065369
Vancouver
Redondo-Castillejo R, Garcimartín A, Hernández-Martín M, López-Oliva ME, Bocanegra A, Macho-González A, et al. Proanthocyanidins: Impact on Gut Microbiota and Intestinal Action Mechanisms in the Prevention and Treatment of Metabolic Syndrome. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24065369
BibTeX
@article{RedondoCastillejo2023,
author = {Redondo-Castillejo, Rocío and Garcimartín, Alba and Hernández-Martín, Marina and López-Oliva, María Elvira and Bocanegra, Aránzazu and Macho-González, Adrián and Bastida, Sara and Benedí, Juana and Sánchez-Muniz, Francisco J},
title = {Proanthocyanidins: Impact on Gut Microbiota and Intestinal Action Mechanisms in the Prevention and Treatment of Metabolic Syndrome},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24065369}
}
EUVIMED